Sibutramine health risks revealed by SCOUT study evoke FDA safety review. Raised cardiovascular side effects for obesity drug force Meridia label upgrade for heart risk.

Jan 28, 2010 - Christine Redmond

FDA announced the withdrawal of sibutramine, a weight loss drug, from the market because studies showed increased risk of stroke and myocardial infarction.

Oct 10, 2010 - Angelica Giron

Diet pill sibutramine (Meridia) withdrawn by Abbott following US FDA request as SCOUT study shows increased cardiovascular risk with weight loss drug's use.

Dec 26, 2010 - Christine Redmond

The old saying goes "you are the company you keep." That appears to be true when it comes to obesity, according to a group of Harvard scientists.

Nov 5, 2010 - Karen Gaskell

Fatal disease from binge eating disorders is America's biggest killer. Understanding the reasons why this has come about could prevent this becoming a worldwide trend.

Oct 11, 2009 - Luke Waterson

Sibutramine health risks may see patients switch to diet pill orlistat for obesity treatment. This article explains Alli and Xenical as weight loss drug options available

Jan 28, 2010 - Christine Redmond

Two new weight loss drugs have recently reported positive results. Availability of Qnexa and Contrave as new obesity treatments in the USA seems to be on the horizon.

Sep 27, 2009 - Christine Redmond

FDA approved prescription weight loss drugs include appetite suppressants & orlistat, a lipase inhibitor that is also the only approved OTC diet pill around

May 20, 2010 - Christine Redmond

Two studies have recently shown how weight and friends are significant factors in decisions made to mold our futures.

Aug 27, 2007 - Barbara Pytel

Weight loss drug sibutramine/Reductil is now banned in Europe due to health risks. As a result of sibutramine's withdrawal, just one obesity drug treatment option is left

Jan 26, 2010 - Christine Redmond

Parents play a pivotal role in battling obesity in children by setting good examples at home with healthy eating habits and physical activity.

May 12, 2010 - Richard Methia

President Barack Obama and Mrs. Obama unveil plans to fight childhood obesity. The nation's children are getting fatter and becoming more unhealthy.

Feb 10, 2010 - Jennifer Terry

On 08 October 2010, responding to a warning from the FDA, the makers of Meridia® (sibutramine), an appetite suppressant, withdrew the drug from the market.

Oct 8, 2010 - James Cooper

Marijuana is blamed by many people for many medical and societal ills out of ignorance - despite recent medical evidence clearing up many of these misconceptions!

Dec 22, 2008 - Nicholas Morine

FDA-approved weight loss drug Meridia/sibutramine may be withdrawn from market or have use restricted following advisory panel safety concerns of diet pill

Sep 17, 2010 - Christine Redmond

Welcome to the brave new world of mind technologies -- a line of non-invasive and seemingly effective tools for boosting brain power.

May 31, 2011 - Mary Desaulniers

SCOUT trial results indicate obesity drug treatment sibutramine (Meridia, Reductil) raises health risks in obese or overweight at high cardiovascular risk, posing concern

Jan 27, 2010 - Christine Redmond

Many drugs now compete for the lucrative weight loss market. As obesity turns into a worldwide pandemic, should overweight men and women use pills to lose weight?

Mar 7, 2010 - Nicolas Henrion

FDA issues orlistat label upgrade to include liver damage risk following safety review. Warning of possible side effects will be added to Xenical and Alli.

May 27, 2010 - Christine Redmond

Weight-loss products flood the market. The 2010 products promising fat loss (and cash in the weight-reduction industry) are Lorcaserin, Qnexa, and Contrave.

Nov 2, 2010 - Marian Henderson